US · Healthcare

Nuvation Bio Inc (NUVB)

Biotechnology

Nuvation Bio Inc (NUVB) is listed on US in the Healthcare sector. Industry: Biotechnology. As of 2026-05-23, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for NUVB

P/E ratio

25.00

Nuvation Bio Inc (NUVB) — FAQ

What is NUVB's P/E ratio?

The price-to-earnings (P/E) ratio for Nuvation Bio Inc (NUVB) is 25.00 (data as of 2026-05-23).

Does Nuvation Bio Inc pay a dividend?

Dividend yield is not available in the current snapshot for Nuvation Bio Inc (NUVB). Check the MyAverix Finance app for the latest dividend data.

What sector is Nuvation Bio Inc in?

Nuvation Bio Inc (NUVB) is classified in the Healthcare sector (Biotechnology industry).

What exchange is NUVB listed on?

NUVB is listed on US.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)